Date published: 2026-4-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ALK Inhibitors

ALK inhibitors belong to a specific chemical class of compounds designed to target and inhibit the activity of Anaplastic Lymphoma Kinase (ALK), a receptor tyrosine kinase that plays a role in various cellular processes including cell growth, proliferation, and survival. ALK is a transmembrane protein and is involved in multiple signaling pathways that contribute to the regulation of cell behavior. ALK inhibitors work by specifically targeting the ALK protein, interfering with its kinase activity and its ability to phosphorylate downstream signaling molecules. By doing so, these inhibitors may modulate the signaling cascades that are activated by ALK, affecting cellular responses associated with growth and survival. Research into ALK inhibitors is ongoing to unravel their precise mechanisms of action and explore their implications in understanding cellular signaling pathways. The study of ALK inhibitors contributes to a deeper understanding of the intricate mechanisms governing cell signaling and regulation.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

VEGFR2 Kinase Inhibitor III

204005-46-9sc-202851
5 mg
$165.00
7
(1)

A VEGFR2 Kinase Inhibitor III compound. It functions as an inhibitor of ALK, a protein involved in cellular processes. Its molecular properties enable targeted interaction with ALK, modulating its activity.

TAE684

761439-42-3sc-364626
sc-364626A
5 mg
50 mg
$188.00
$988.00
2
(1)

A powerful inhibitor of ALK. It targets NPM-ALK phosphorylation, leading to cell cycle arrest and apoptosis in Ba/F3 cell lines. Effective against Ba/F3 NPM-ALK cells. it spares general cell viability. It also restrains proliferation in NPM-ALK-expressing human ALCL cell like Karpas-299 and SU-DHL-1.

A 77-01

607737-87-1sc-396001
5 mg
$194.00
(0)

Recognized for its capability to inhibit ALK5, a prominent member of the TGF-β type I receptor superfamily. A 77-01 effectively interferes with ALK5's functionality, highlighting its potential as a tool compound for modulating TGF-β signaling pathways.

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

A potent ALK inhibitor that competes with ATP. By inhibiting autophosphorylation, it curbs ALK activity and suppresses STAT3 and AKT phosphorylation (not ERK1/2). CH5424802 triggers apoptotic marker caspase-3/7-like activation in NCI-H2228 spheroid cells. Effective against NPM-ALK-expressing lymphoma lines KARPAS-299 and SR, it notably hinders KARPAS-299 growth.

SB-505124

694433-59-5sc-362794
sc-362794A
10 mg
50 mg
$327.00
$1377.00
2
(0)

Functions as an ALK inhibitor, impeding the activity of the receptor. It operates by blocking the ALK signaling pathway, which plays a role in various cellular processes.

GW788388

452342-67-5sc-363544
sc-363544A
5 mg
25 mg
$95.00
$384.00
(0)

An ALK inhibitor, specifically targeting ALK5, a member of the TGF-β receptor superfamily. It effectively impedes ALK5's signaling activity, modulating cellular processes associated with this pathway.